Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China flag China · Delayed Price · Currency is CNY
17.39
-0.43 (-2.41%)
Nov 17, 2026, 3:04 PM CST

SHE:300255 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
72.08128236.44230.92797.8543.21
Cash & Short-Term Investments
72.08128236.44230.92797.8543.21
Cash Growth
-70.92%-45.86%2.39%-71.06%46.87%12.93%
Accounts Receivable
423.82251.19265.74238.08452.99317.09
Other Receivables
13.6658.3642.5580.4343.0339.24
Receivables
437.48309.55308.29318.52496.02356.33
Inventory
1,0551,2321,3861,6442,4312,285
Prepaid Expenses
-0.090.08-0.020.29
Other Current Assets
54.1442.2271.8682.14172.24223.68
Total Current Assets
1,6191,7122,0022,2763,8983,408
Property, Plant & Equipment
1,8131,7901,7131,5911,4831,193
Long-Term Investments
----1.465.8
Goodwill
----1.783.56
Other Intangible Assets
316.27313.57308.13320.55263.82274.06
Long-Term Deferred Tax Assets
11.9819.4321.8920.9711.7814
Long-Term Deferred Charges
519.43493.62432.58361.03286.26219.84
Other Long-Term Assets
16.5522.3144.3226.6589.8271.56
Total Assets
4,2964,3514,5234,5966,0365,190

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
334.89434.64307.47263.38249.81106.49
Accrued Expenses
22.4529.4228.1737.4654.2536.57
Short-Term Debt
1,5221,318887.55967.221,0101,272
Current Portion of Long-Term Debt
390.28540.13873.18586.14351.6134.22
Current Portion of Leases
-80.2856.880.39--
Current Income Taxes Payable
13.480.892.361.143.4523.62
Current Unearned Revenue
12.919.8214.5320.847.4565.86
Other Current Liabilities
116.7270.8132.6544.471.6595.31
Total Current Liabilities
2,4132,4842,2031,9211,7881,734
Long-Term Debt
682.57584.32659.47811.761,129332.47
Long-Term Leases
7.8142.2564.441.26--
Long-Term Unearned Revenue
65.3866.7360.0162.4864.851.02
Long-Term Deferred Tax Liabilities
0.230.260.310.350.190.2
Other Long-Term Liabilities
5.275.27----
Total Liabilities
3,1743,1832,9872,7972,9822,118

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
919.06919.06919.06919.06934.97934.97
Additional Paid-In Capital
422.74422.74422.74422.74526.84526.84
Retained Earnings
-175.27-137.38220.52469.991,7941,800
Treasury Stock
-----120.01-120.01
Comprehensive Income & Other
0.01-0.27-0.05-0.13-77.86-73.5
Total Common Equity
1,1671,2041,5621,8123,0583,069
Minority Interest
-44.34-36.08-26.52-11.97-4.023.34
Shareholders' Equity
1,1221,1681,5361,8003,0543,072
Total Liabilities & Equity
4,2964,3514,5234,5966,0365,190

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
2,6032,5652,5422,3672,4901,739
Net Cash (Debt)
-2,531-2,437-2,305-2,136-1,692-1,195
Net Cash Growth
------
Net Cash Per Share
-2.65-2.66-2.49-2.32-1.93-1.28
Filing Date Shares Outstanding
919.06919.06919.06919.06919.06919.06
Total Common Shares Outstanding
919.06919.06919.06919.06919.06919.06
Working Capital
-794.02-772.01-200.38354.942,1101,674
Book Value Per Share
1.271.311.701.973.333.34
Tangible Book Value
850.27890.571,2541,4912,7922,791
Tangible Book Value Per Share
0.930.971.361.623.043.04
Buildings
-936.24932.88915.66808.9701.24
Machinery
-538.89538.71545.8389.26339.53
Construction In Progress
-839.2708.97547.74642.27462.72